Portfolio vs. Benchmark (Q1)
Asset Allocation
$4.29M
Total Assets
Client Review
Portfolio Review
The Thompson Family Trust · Account #8847-QR
Portfolio Value
$4,287,400
▲ +$90K market · +$45K contributions
YTD Return
+2.15%
▲ 6.78% above S&P 500
Income Generated
$38,540
Dividends + interest
Net Contributions
+$45,000
IRA + taxable
Top Positions
Top 5 by market value| Security | Type | Market Value | Q1 Change |
|---|
Wealth Target Progression
2026 Plan$3M
Baseline
2025
2025
$4M
Reached
Dec 2025
Dec 2025
$4.29M
Current
Q1 2026
Q1 2026
$5M
Target
Q4 2026
Q4 2026
$7.5M
Retirement
2032
2032
Portfolio vs. Blended Benchmark (60/40)
Cumulative
Annualized
vs. 60/40
vs. S&P 500
Best Week
Max Drawdown
Current Allocation
as of Mar 31, 2026$4.29M
Across 5 classes
Target vs. Actual
drift ≥3% flaggedAll Equity & Fixed Income Positions
Ranked by market value| Security | Shares | Price | Market Value | % of Portfolio | Q1 Change |
|---|
Monthly Income
Trailing 12MIncome by Source
$145.8k
12-month total
Risk Metrics
Trailing 3YBeta
0.86
Moves ~14% less than the market.
Std. Deviation
11.4%
Annualized. Benchmark: 12.8%.
Sharpe Ratio
0.92
Return per unit of risk.
Max Drawdown
-8.2%
Largest 3Y peak-to-trough.
Advisor Commentary
TB
Toby Brazzel, CFP®
Principal · Brazzel Wealth Management
Key Takeaways
- Positive quarter (+2.15%) while S&P 500 fell 4.63%
- Outperformed S&P 500 by +6.78%
- Outperformed 60/40 blended benchmark by +3.65%
- Max drawdown limited to −0.80% vs. S&P's deeper decline
- On track for 2026 income target of $155K
The first quarter was a difficult one for equity markets. The S&P 500 finished Q1 down 4.63%, its worst quarter since 2022, pressured by geopolitical tension in the Middle East, crude oil volatility, and rotation out of mega-cap technology.
Your portfolio closed the quarter up 2.15%. That is a 6.78% spread against pure equity and a 3.65% spread against the 60/40 blended benchmark. Both reflect the defensive positioning we set heading into the year: underweight mega-cap tech, overweight short-duration Treasuries, and meaningful exposure to dividend-paying quality names that held up through the March drawdown.
Three moves shaped the quarter: we trimmed 2% from developed international in mid-February ahead of the March volatility, we added to short-Treasury exposure on the February rally, and we held our healthcare weight as it outperformed the broader market.
Looking forward: the portfolio is built to participate less on the upside than a pure equity allocation and protect meaningfully on the downside. Q1 reflected exactly that trade-off working as designed. No material strategy changes are planned for Q2 absent a change in your goals.